Skip to main content
logo
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.21
+0.06 (0.54%)
At close: Mar 20, 2026, 4:00 PM EDT
11.43
+0.22 (1.96%)
After-hours: Mar 20, 2026, 7:42 PM EDT

Phathom Pharmaceuticals Revenue

In the year 2025, Phathom Pharmaceuticals had annual revenue of $175.11M with 216.93% growth. Phathom Pharmaceuticals had revenue of $57.58M in the quarter ending December 31, 2025, with 94.12% growth.

Revenue (ttm)
$175.11M
Revenue Growth
+216.93%
P/S Ratio
5.04
Revenue / Employee
$471,995
Employees
371
Market Cap
883.33M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025175.11M119.86M216.93%
Dec 31, 202455.25M54.57M8,001.47%
Dec 31, 2023682.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortrea Holdings2.72B
Valneva SE205.07M
Xencor125.58M
UroGen Pharma109.79M
Janux Therapeutics10.00M
KalVista Pharmaceuticals1.43M
Inhibrx Biosciences1.30M
Compass Therapeutics850.00K
Revenue Rankings

PHAT News

More News